**Recent federal actions have advanced marijuana rescheduling under the Controlled Substances Act.** In April 2026, the Department of Justice issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, following a December 2025 executive order directing expedited review. A separate administrative hearing on broader rescheduling from Schedule I to III ran from late June to mid-July 2026, with the DEA filing post-hearing briefs in August arguing that marijuana no longer meets Schedule I criteria due to accepted medical use. On September 9, 2026, the D.C. Circuit rejected challenges seeking to block the process, allowing it to continue while an administrative law judge weighs a recommendation. Opposing briefs from states and advocacy groups remain part of the record, and further review by the DEA Administrator or courts could still affect timing.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$809,884 ปริมาณ
Dec 31, 2026
September 30
4%
December 31
16%
$809,884 ปริมาณ
September 30
$660 ปริมาณ
4%
December 31
$199,654 ปริมาณ
16%
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), between market creation and September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.**Recent federal actions have advanced marijuana rescheduling under the Controlled Substances Act.** In April 2026, the Department of Justice issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, following a December 2025 executive order directing expedited review. A separate administrative hearing on broader rescheduling from Schedule I to III ran from late June to mid-July 2026, with the DEA filing post-hearing briefs in August arguing that marijuana no longer meets Schedule I criteria due to accepted medical use. On September 9, 2026, the D.C. Circuit rejected challenges seeking to block the process, allowing it to continue while an administrative law judge weighs a recommendation. Opposing briefs from states and advocacy groups remain part of the record, and further review by the DEA Administrator or courts could still affect timing.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Feb 7, 2026, 5:04 PM ET
ปริมาณการซื้อขาย
$809,884วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
Feb 7, 2026, 5:04 PM ETผู้ตัดสินผล
0x65070BE91...This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), between market creation and September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.**Recent federal actions have advanced marijuana rescheduling under the Controlled Substances Act.** In April 2026, the Department of Justice issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, following a December 2025 executive order directing expedited review. A separate administrative hearing on broader rescheduling from Schedule I to III ran from late June to mid-July 2026, with the DEA filing post-hearing briefs in August arguing that marijuana no longer meets Schedule I criteria due to accepted medical use. On September 9, 2026, the D.C. Circuit rejected challenges seeking to block the process, allowing it to continue while an administrative law judge weighs a recommendation. Opposing briefs from states and advocacy groups remain part of the record, and further review by the DEA Administrator or courts could still affect timing.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
ปริมาณการซื้อขาย
$809,884วันสิ้นสุด
Jan 1, 2027ตลาดเปิดเมื่อ
Feb 7, 2026, 5:04 PM ETผู้ตัดสินผล
0x65070BE91...**Recent federal actions have advanced marijuana rescheduling under the Controlled Substances Act.** In April 2026, the Department of Justice issued a final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, following a December 2025 executive order directing expedited review. A separate administrative hearing on broader rescheduling from Schedule I to III ran from late June to mid-July 2026, with the DEA filing post-hearing briefs in August arguing that marijuana no longer meets Schedule I criteria due to accepted medical use. On September 9, 2026, the D.C. Circuit rejected challenges seeking to block the process, allowing it to continue while an administrative law judge weighs a recommendation. Opposing briefs from states and advocacy groups remain part of the record, and further review by the DEA Administrator or courts could still affect timing.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย